Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Allergy ; 65(8): 978-85, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20002661

ABSTRACT

BACKGROUND: Recent studies performing fiberoptic bronchoscopy in children have improved our understanding of asthma pathophysiology. Eosinophilic, but also neutrophilic, inflammation has been described in asthma, but the relationship with atopy was incompletely investigated. The aim of this study is to examine inflammatory cells and mediators in children with asthma compared to the appropriate controls, i.e. atopic children without asthma and children with no atopy or asthma. Moreover, asthmatic children were analysed separately based on the presence of atopy and stratified by age. METHODS: We recruited 191 children undergoing fiberoptic bronchoscopy for appropriate indications: 91 asthmatics (aged 1.4-17 years), 44 atopics without asthma (1.6-17.8 years) and 56 nonasthmatic nonatopic controls (1.4-14 years). In bronchoalveolar lavage, total and differential cell counts and inflammatory mediators, including ECP, eotaxin, IL-8 and TNFalpha, were analysed. RESULTS: Eosinophils and ECP levels were increased in asthmatic children when compared to controls (P = 0.002 and P = 0.01, respectively), but also atopic children without asthma had increased ECP levels compared to controls (P = 0.0001). Among asthmatic children, eosinophils and ECP levels were not different between atopic and nonatopic individuals. Neither neutrophils nor the related mediators (IL-8 and TNFalpha) differed significantly in the three groups. This pattern of inflammation was observed in both preschool and school-aged asthmatic children. CONCLUSIONS: This study suggests that markers of eosinophilic, but not neutrophilic inflammation, are increased in asthmatic children and also in atopic children without asthma. Of interest, in asthmatic children, the activation of the eosinophilic response is not solely because of the presence of atopy.


Subject(s)
Asthma/immunology , Bronchoalveolar Lavage Fluid/immunology , Eosinophils/immunology , Hypersensitivity, Immediate/immunology , Inflammation Mediators/analysis , Neutrophils/immunology , Adolescent , Asthma/physiopathology , Bronchoalveolar Lavage Fluid/cytology , Child , Child, Preschool , Eosinophilia/immunology , Eosinophilia/metabolism , Eosinophils/cytology , Female , Humans , Hypersensitivity, Immediate/physiopathology , Infant , Inflammation/immunology , Leukocyte Count , Male , Neutrophils/cytology
2.
Phytother Res ; 21(7): 684-9, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17444577

ABSTRACT

According to folk medicine some species belonging to the genus Cyclamen were used for their biological activities. Early investigation of the different species of the genus resulted in the isolation of triterpenic saponins. No phytochemical and biological data are available on C. repandum. As part of a series of phytochemical investigations for bioactive compounds from medicinal plants, Cyclamen repandum S. et S. was investigated. The present study sought to find the antiinflammatory and antinociceptive activities of C. repandum tubers in rats and mice. A preliminary screening was conducted with three different extracts in the tests used, particularly the paw edema and the writhing tests. Subsequently some saponins isolated from the ME extract, the more effective one, have been identified. This paper also describes the results of fractionation and bioassay guided chemical studies. Chemical investigation of the active extract afforded the isolation and characterization of six triterpenic saponins. The possible antiinflammatory and analgesic properties were investigated as the saponin content of the fractions allows to speculate on such aspect.


Subject(s)
Analgesics/pharmacology , Anti-Inflammatory Agents/pharmacology , Cyclamen , Edema/prevention & control , Pain/prevention & control , Phytotherapy , Plant Extracts/pharmacology , Acetic Acid , Analgesics/administration & dosage , Analgesics/therapeutic use , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Carrageenan , Edema/chemically induced , Male , Mice , Pain/chemically induced , Pain Measurement/drug effects , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Rats , Rats, Sprague-Dawley
3.
Eur Ann Allergy Clin Immunol ; 35(2): 47-51, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12674038

ABSTRACT

A cross-sectional study was conducted on among 28,856 children aged from birth to 14 years to determine the prevalence of asthma and assess its treatment in a sample of asthmatic children. Children diagnosed with asthma were identified by a sensitive algorithm applied to the information stored in the computerized medical records between 1997 and 1998. Pediatricians then reviewed and validated the diagnosis. Specific information was obtained, after age stratification under 5 yrs and over 6 ys, from the medical records and by interview regarding their personal details and treatment of asthmatic patients. In all, 1,263 cases of asthma were identified (64% males) with a prevalence of 6.3% among males and 4% among females in under 5 year-olds, and 3.9% for males and 2.1% for females in over 6 year-olds. The prevalence of asthma diagnosed directly by the pediatrician was consequently higher among under 5 year-olds, in both genders, than among the older children. Contrary to the international guidelines, pediatricians prescribed more oral corticosteroids and nebulized short-acting beta-2 agonists for children under 5 ys olds than for over 6 year-olds (13.3% Vs 4.8% and 25% Vs 10.9%, respectively, p < 0.001). For the > or = 6 year-olds, the most commonly prescribed treatments were oral antihistamines (13.9% Vs 12.6%), inhaled corticosteroids via metered-dose inhaler (30.8% Vs 28.7%) and sodium cromoglycate (12.1% Vs 4.8%, p < 0.001).


Subject(s)
Anti-Asthmatic Agents/therapeutic use , Asthma/epidemiology , Adolescent , Adrenal Cortex Hormones/therapeutic use , Adrenergic beta-Antagonists/therapeutic use , Asthma/drug therapy , Child , Child, Preschool , Cholinergic Antagonists/therapeutic use , Cromolyn Sodium/therapeutic use , Cross-Sectional Studies , Databases, Factual , Drug Administration Routes , Drug Prescriptions/statistics & numerical data , Drug Utilization/statistics & numerical data , Female , Histamine H1 Antagonists/therapeutic use , Humans , Infant , Infant, Newborn , Italy/epidemiology , Male , Medical Records Systems, Computerized , Practice Patterns, Physicians'/statistics & numerical data , Prevalence , Retrospective Studies
4.
Pediatr Pulmonol ; 35(1): 50-5, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12461739

ABSTRACT

Urokinase is an enzyme with a fibrinolytic effect that facilitates pleural empyema drainage through a chest tube. The aim of this study was to assess the risk of pneumothorax, the need for pleural debridement surgery, the persistence of fever, and the number of days in hospital in a group of children with parapneumonic pleural empyema treated with urokinase. This was an uncontrolled retrospective study on children suffering from parapneumonic empyema. Data collected on 17 children treated with urokinase were compared with 11 children treated prior to the advent of urokinase (the "historic" group). The urokinase was instilled in the pleural cavity over a period ranging from 2-8 days, amounting to a median total dose per kilogram of body weight of 18,556 IU (range, 7,105-40,299). Surgical treatment of the empyema involved drainage tube placement and/or debridement of the pleural cavity. Three children developed pneumothorax during their hospital stay, and one more case occurred 6 months after the child had recovered from his empyema; there were 3 cases of pneumothorax during the acute phase in the "historic" group (P = 0.54). Five children in the urokinase group were debrided and 12 were only drained, as opposed to 9 and 2, respectively, in the "historic" group (P = 0.02). The overall hospital stay was 17 days for the urokinase group, and 24 for the "historic" group (P = 0.02). No bleeding or other major complications were reported in the group treated with urokinase. In conclusion, urokinase treatment does not carry a risk of pneumothorax, while it does reduce hospital stay and the need for pleural debridement.


Subject(s)
Empyema, Pleural/drug therapy , Plasminogen Activators/therapeutic use , Urokinase-Type Plasminogen Activator/therapeutic use , Child , Child, Preschool , Debridement , Empyema, Pleural/complications , Empyema, Pleural/economics , Empyema, Pleural/surgery , Female , Humans , Length of Stay , Male , Plasminogen Activators/economics , Pneumothorax/etiology , Retrospective Studies , Urokinase-Type Plasminogen Activator/economics
5.
Pediatr Med Chir ; 25(4): 285-8, 2003.
Article in Italian | MEDLINE | ID: mdl-15070274

ABSTRACT

The Authors report a 10-years-old boy who was diagnosed as having upper esophageal stenosis. Biopsies of the stricture showed heterotopic gastric mucosa; endoscopic treatment was safe and effective.


Subject(s)
Choristoma/complications , Deglutition Disorders/etiology , Esophageal Diseases/complications , Gastric Mucosa , Child , Humans , Male
6.
Pediatr Pulmonol ; 31(5): 394-7, 2001 May.
Article in English | MEDLINE | ID: mdl-11340687

ABSTRACT

Bronchiolitis obliterans with organizing pneumonia (BOOP) is rarely described in children and little is known about its pathogenesis. This paper reports on an 11-year-old patient suffering from mild-to-moderate asthma. He presented with a retrocardiac density at chest computed tomography scan that was slow to resolve and failed to respond to antibiotic therapy. Open lung biopsy revealed a histological picture with buds of granulation tissue in respiratory bronchioles and alveolar ducts, with organized extensions into the alveoli. The use of monoclonal antibodies on biopsy specimens demonstrated the presence of an inflammatory process affecting not only the thickened alveolar walls, but also the remaining lung parenchyma, the pulmonary arteries, and the bronchioles. The inflammatory infiltrate consisted mainly of mast cells and eosinophils. The clinical condition improved with steroid therapy. To the best of the authors' knowledge, this is the first report of BOOP in an asthmatic child with recruitment of mast cells and eosinophils documented by using monoclonal antibodies.


Subject(s)
Asthma/complications , Cryptogenic Organizing Pneumonia/complications , Cryptogenic Organizing Pneumonia/diagnosis , Eosinophils/pathology , Lung/pathology , Mast Cells/pathology , Asthma/pathology , Asthma/physiopathology , Child , Cryptogenic Organizing Pneumonia/physiopathology , Eosinophils/physiology , Humans , Lung/physiopathology , Male , Mast Cells/physiology
7.
Pediatr Allergy Immunol ; 12(2): 73-7, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11338289

ABSTRACT

Little information is available on cell profiles and mediator production in the lower airways of children with asthma by comparison with the adult population. To study the bronchoalveolar lavage (BAL) cell profiles and production of eosinophil cationic protein (ECP) and myeloperoxidase (MPO) in childhood bronchial asthma, a retrospective study was performed in 29 children (13 allergic asthmatic children and 16 controls). Six of the asthmatics had mild-to-moderate persistent disease and seven had intermittent asthma. The BAL cell count and ECP and MPO values of asthmatic children were compared with those from 16 controls. The asthmatic patients had higher values than controls for the total cell count (p = 0.08), for neutrophils (p = 0.02), and for ECP and MPO (p < 0.001). MPO levels (p = 0.04), neutrophil count (p = 0.06), and ECP values (p = 0.06) were higher in patients with mild-to-moderate persistent asthma than in those with intermittent asthma. Our results demonstrate that neutrophil-mediated inflammation is greater in patients with more severe asthma.


Subject(s)
Asthma/immunology , Bronchoalveolar Lavage Fluid/immunology , Neutrophil Activation , Ribonucleases , Adolescent , Blood Proteins/analysis , Bronchoalveolar Lavage Fluid/cytology , Child , Child, Preschool , Eosinophil Granule Proteins , Eosinophils/immunology , Eosinophils/metabolism , Female , Humans , Leukocyte Count , Male , Peroxidase/analysis , Retrospective Studies
8.
Eur Respir J ; 16(3): 509-13, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11028669

ABSTRACT

Chronic interstitial lung disease (ILD) is a rare disorder in the paediatric age group, with a poor prognosis. The diagnostic approach to ILD is based on more or less invasive methods. This study was implemented to verify which methods are the most often used in children. Questionnaires (333) were sent to members of the European Respiratory Society Paediatric Assembly belonging to 187 European and non-European centres. Questions concerned the use of noninvasive diagnostic methods, e.g. history taking, physical examination, routine laboratory tests, respiratory function tests and radiology (chest radiography, high-resolution computed tomography (HRCT)), and the use of invasive techniques such as bronchoalveolar lavage (BAL), transbronchial biopsy (TBB), open lung biopsy (OLB), video-assisted thoracoscopic biopsy (VAT) and HRCT with fine-needle aspiration biopsy (FNAB). Thirty eight centres returned the questionnaires and 131 children with ILD were studied. A diagnosis of ILD was achieved in five (3.8%) patients using noninvasive techniques alone. Using the various biopsy methods, histological assessment was performed on a total of 98 (74.8%) children. The most frequently used invasive technique both alone and in combination was BAL (83, 63.3%), followed by OLB (64, 48.8%), TBB (26, 19.8%) and VAT (11, 8.4%); FNAB was used in one patient. In conclusion a diagnosis of interstitial lung disease was reached on the basis of aetiological and/or histological findings in 117 (89%) of the 131 patients studied.


Subject(s)
Lung Diseases, Interstitial/diagnosis , Lung Diseases, Interstitial/epidemiology , Adolescent , Child , Child, Preschool , Chronic Disease , Female , Humans , Infant , Male , Surveys and Questionnaires
10.
Paediatr Respir Rev ; 1(2): 172-8, 2000 Jun.
Article in English | MEDLINE | ID: mdl-12531111

ABSTRACT

Chronic interstitial lung disease (ILD) is rare in children, but is clinically relevant because of its high morbidity and mortality rates. Several aetiological agents may have a role in this disease and various aetiopathogenic forms have been described, although they share a characteristic evolution towards pulmonary fibrosis. The aetiology sometimes remains unknown, in which case we speak of idiopathic interstitial pneumonia (IIP). Diagnosis relies on non-invasive methods (clinical history, respiratory function tests, chest X-ray and high-resolution CT scan) and invasive techniques (bronchoalveolar lavage, transbronchial biopsy, video-assisted thoracoscopic biopsy and open lung biopsy); the latter are used when the former fail to identify an aetiological agent. The gold standard for the diagnosis is lung biopsy, however, which also enables the classification of the idiopathic forms, in particular (usual interstitial pneumonia, desquamative interstitial pneumonia, non-specific interstitial pneumonia, and so on). In ILD, the most common therapeutic approaches involve the use of oral steroids and hydroxychloroquine sulphate for its anti-inflammatory and antifibrotic effect. The prognosis is often poor.


Subject(s)
Lung Diseases, Interstitial/diagnosis , Lung Diseases, Interstitial/therapy , Child , Chronic Disease , Humans , Lung Diseases, Interstitial/classification , Lung Diseases, Interstitial/etiology , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...